Newark, March 11, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 17.47 Billion in 2023 paper diagnostics market will reach USD 36.78 Billion by 2033. Paper-based assays can provide a feasible route for disease management in resource-constrained settings where the costly diagnostic assays currently in use are inappropriate due to their transparency with cellulose and flexibility. In point-of-care (POC) settings, these portable devices are very useful for environmental monitoring, food safety, water testing, and disease diagnoses. These broader usage are driving the growth of the paper diagnostics market. When compared to alternative approaches, paper diagnostics are preferred because they are affordable, easily accessed, flammable, biodegradable, hydrophilic, biocompatible, easy to functionalize, and may be processed into diagnostic devices. Growing acceptance, accessibility, investment, and increased applications of paper diagnostics techniques are some of the factors driving the paper diagnostics market.
Download Report Sample (230+ Pages PDF with Insights) at: https://www.thebrainyinsights.com/enquiry/sample-request/14082
Report Attribute Details
| Report Attribute | Details |
| Revenue forecast in 2023 | USD 17.47 Billion |
| Market size value in 2033 | USD 36.78 Billion |
| Expected CAGR Growth | 7.73% |
| Base Year | 2023 |
| Forecast Year | 2024 - 2033 |
| Top Market Players | Acon Laboratories, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare Gmbh, Ffei Life Science (Biognostix), Micro Essential Laboratory Inc., Arkray, Inc., Gvs S.P.A., Navigene, Abbott (Alere Inc.), Kenosha Tapes, Diagnostics For All, Inc. |
| Segments Covered | by Kit Type, Device Type, Regions |
| Customization Options | Customized purchase options are available to meet any research needs. Explore customized purchase options |
Key Insight of the Paper Diagnostics Market
Asia Pacific is anticipated to expand at the highest CAGR of 9.83% over the projection period.
Asia Pacific is expected to grow at the highest CAGR of 9.83% over the forecast period. It may be the consequence of growing public spending on healthcare, a number of government programmes, education, and heightened health consciousness. Over the course of the projection period, the Indian market is expected to grow at the quickest rate. The primary drivers of this growth are the growing demand from rural populations for affordable diagnostic instruments and the acceleration of product development by regional competitors.
The paper based microfluidics segment is expected to register the highest CAGR of 10.57% over the projected period in the paper diagnostics market.
The paper based microfluidics segment is anticipated to grow at the highest CAGR of 10.57% in the paper diagnostics market. It's because life sciences and pharmaceutical businesses are investing more in R&D and there is a growing demand for point-of-care diagnostics. The FDA approved ACON Laboratories, Inc.'s over-the-counter (OTC) Distinct Early Detection Pregnancy test in December 2020. The test is a fast chromatographic immunoassay that can identify human chorionic gonadotropin (hCG) in urine. Pregnancy can be identified by the kit up to six days sooner.
Over the projected period, the monitoring devices segment is expected to register the highest CAGR of 8.28% in the paper diagnostics market.
Over the forecasted period, the monitoring devices segment is anticipated to grow at the highest CAGR of 8.28% in the paper diagnostics market. This is explained by the fact that the application—which includes nutrient monitoring in aquatic systems and food testing—is using more and more equipment. Additionally, the growing use of improved monitoring by agricultural groups and government agencies like the Ministry of Food Processing and the International Food Protection Training Institute would bolster the market's expansion.
Inquiry Before Buying: https://www.thebrainyinsights.com/enquiry/buying-inquiry/14082
Market Dynamics
Driver: Increasing need for quick and distributed diagnostic tools
The growing demand for prompt and decentralised diagnostic solutions is one of the primary drivers driving the growth of the paper diagnostics market. When timely and reliable healthcare results are critical at the point of service, paper diagnostics provide an appealing substitute. Because paper-based assessments are inexpensive and simple to administer, they are particularly well-suited for usage in a range of settings. These situations include remote areas with little access to cutting-edge laboratory resources and emergency situations where a timely diagnosis is essential. In the increasingly complex global healthcare environment, paper diagnostics are essential to meeting the demands of early detection and prompt action.
Restraint: Concerns about specificity and sensitivity
It's possible that worries regarding sensitivity and specificity will reduce the market's demand for paper diagnostics. Although there are advantages to paper-based diagnostic tests, such as mobility, affordability, and ease of use, their sensitivity and specificity may hinder their widespread adoption. If paper diagnostics prove limited in their ability to identify or rule out particular conditions, then both healthcare providers and end users may lose confidence in them. When deciding how to treat a patient, diagnostic data accuracy is vital. The inherent limitations of paper-based testing may make it challenging to attain high sensitivity and specificity levels, as these methods may not always outperform more advanced laboratory techniques. When reliable diagnostic results are crucial, healthcare professionals may be hesitant to rely solely on paper diagnostics.
Opportunity: Quick testing in case of emergency
The demand for prompt and decentralised diagnostic solutions, particularly in emergency situations, presents a significant opportunity for the paper diagnostics market. Tests that are paper-based have a few advantages over other test formats, including portability, user-friendliness, and quick turnaround times. They are a valuable tool for emergency response scenarios because of these benefits. For timely decision-making and effective containment strategies in the event of a disease epidemic, natural disaster, or public health emergency, rapid on-site testing becomes essential. Healthcare professionals may rapidly detect and treat infections in emergency situations by using paper diagnostics, which offer a convenient and rapid way to diagnose infectious diseases.
Browse the full report with Table of Contents and List of Figures: https://www.thebrainyinsights.com/report/paper-diagnostics-market-14082
Some of the major players operating in the paper diagnostics market are:
• Acon Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• Siemens Healthcare Gmbh
• Ffei Life Science (Biognostix)
• Micro Essential Laboratory Inc.
• Arkray, Inc.
• Gvs S.P.A.
• Navigene
• Abbott (Alere Inc.)
• Kenosha Tapes
• Diagnostics For All, Inc.
Key Segments cover in the market:
By Kit Type:
• Dipsticks
• Lateral Flow Assays
• Paper Based Microfluidics
By Device Type:
• Monitoring Devices
• Diagnostic Devices
By Region
• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America)
• The Middle East and Africa (UAE, South Africa, Rest of MEA)
About the report:
The market is analyzed based on value (USD Billion). All the segments have been analyzed worldwide, regional, and country basis. The study includes the analysis of more than 30 countries for each part. The report analyzes driving factors, opportunities, restraints, and challenges for gaining critical insight into the market. The study includes porter's five forces model, attractiveness analysis, product analysis, supply, and demand analysis, competitor position grid analysis, distribution, and marketing channels analysis.
About The Brainy Insights:
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirements whether they are looking to expand or planning to launch a new product in the global market.
Contact Us
Avinash D
Head of Business Development
Phone: +1-315-215-1633
Email: sales@thebrainyinsights.com
Web: www.thebrainyinsights.com
